Elliott's Stake In Imperva Further Affirms Co.'s Long-Term Potential Valuation

Imperva Inc IMPV shares have rallied around 12 percent Tuesday following an SEC filing Monday afternoon which showed a new 9.8 percent stake by Elliott Associates.

Oppenheimer analyst Shual Eyal offered comments on Imperva Tuesday amid the filing.

"We have been long arguing that IMPV's current price does not fully reflect its market opportunity, growth potential, and genuine valuation. We continue to view IMPV as having a strong leadership position within the web application firewall (WAF), database activity monitoring (DAM) and file activity monitoring (FAM) market given a robust end-to-end platform (on-and-off premise) serving both the SMB and high-end markets," Eyal said.

"In a rapidly consolidating security environment, we view Elliott's stake as further affirmation of IMPV's LT potential valuation that could be further unlocked through strategic moves," the Oppenheimer analyst continued.

Eyal reiterated an Outperform rating and $60 price target on shares of Imperva.

Market News and Data brought to you by Benzinga APIs
Posted In: Analyst ColorNewsHedge FundsReiterationAnalyst RatingsGeneral
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...